Orthosera GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Orthosera GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11270
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Orthosera GmbH (OrthoSera), formerly Lacerta Technologies GmbH is a regenerative medicine company that develops blood serum for human diseases. The company offers Albumin, a bone protein used in treatment of patients suffering from bone loss. It develops technologies for identification of new disease areas and to advance development of pipeline products in orthopedic, dental and spine applications. OrthoSera also offers BoneAlbumin and hyper acute serum. The company’s BoneAlbumin is a bone void filler used in dentistry and orthopaedics. It conducts research on bone grafting, wound healing, osteoarthritis, and dental and orthopedic indications. OrthoSera is headquartered in Krems an der Donau, Austria.

Orthosera GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Orthosera GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Orthosera GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Orthosera GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
OrthoSera Raises Funds through Series B Financing 11
OrthoSera Raises Funds in Financing Round 12
Lacerta Technologies Raises Funds Through Seed Financing 13
Orthosera GmbH – Key Competitors 14
Orthosera GmbH – Key Employees 15
Orthosera GmbH – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Orthosera GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Orthosera GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Orthosera GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Orthosera GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
OrthoSera Raises Funds through Series B Financing 11
OrthoSera Raises Funds in Financing Round 12
Lacerta Technologies Raises Funds Through Seed Financing 13
Orthosera GmbH, Key Competitors 14
Orthosera GmbH, Key Employees 15

List of Figures
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Orthosera GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Orthosera GmbH, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Orthosera GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sensus Healthcare Inc (SRTS):医療機器:M&Aディール及び事業提携情報
    Summary Sensus Healthcare Inc (Sensus) designs, manufactures and markets proprietary medical devices for the treatment of various types of cancers and skin diseases. The company offers superficial radiation therapy (SRT) technology based non-surgical treatment options for patients suffering from var …
  • Angle Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Angle Biosciences Inc (Angle Biosciences), formerly Axela Inc, is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers …
  • Monteloeder S.L.:企業の戦略・SWOT・財務情報
    Monteloeder S.L. - Strategy, SWOT and Corporate Finance Report Summary Monteloeder S.L. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Mechel:企業のM&A・事業提携・投資動向
    Mechel - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mechel Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital rais …
  • STMicroelectronics N.V. (STM)-医療機器分野:企業M&A・提携分析
    Summary STMicroelectronics N.V. (ST) is a microelectronics company that designs, develops, manufactures, and markets a broad range of products for analog, digital, and mixed-signal applications. It offers standard commodity components, custom devices and semi-custom devices, application-specific int …
  • Tetra Technologies, Inc.:企業の戦略・SWOT・財務分析
    Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Archer Daniels Midland Co:戦略・SWOT・企業財務分析
    Archer Daniels Midland Co - Strategy, SWOT and Corporate Finance Report Summary Archer Daniels Midland Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Financial and Strategic SWOT Analysis Review
    Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportuni …
  • Reno de Medici S.p.A.:企業の戦略・SWOT・財務情報
    Reno de Medici S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Reno de Medici S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Fuji Seal International Inc.:戦略・SWOT・企業財務分析
    Fuji Seal International Inc. - Strategy, SWOT and Corporate Finance Report Summary Fuji Seal International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • DePuy Synthes Inc:企業の戦略的SWOT分析
    DePuy Synthes Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Magnis Resources Limited (MNS):企業の財務・戦略的SWOT分析
    Magnis Resources Limited (MNS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Harvard Stem Cell Institute-製薬・医療分野:企業M&A・提携分析
    Summary Harvard Stem Cell Institute (HSCI), a subsidiary of Harvard University is a healthcare institute that conducts research on advance stem cell science using stem cell biology to develop new treatments and cures for disease. The institute provides research programs such as disease programs, cor …
  • Imperial Dax Company, Inc:企業の戦略・SWOT・財務情報
    Imperial Dax Company, Inc - Strategy, SWOT and Corporate Finance Report Summary Imperial Dax Company, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • The National Commercial Bank
    The National Commercial Bank - Strategy, SWOT and Corporate Finance Report Summary The National Commercial Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • The J. R. Simplot Co:企業の戦略・SWOT・財務情報
    The J. R. Simplot Co - Strategy, SWOT and Corporate Finance Report Summary The J. R. Simplot Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Paladin Energy Ltd.:企業の戦略的SWOT分析
    Paladin Energy Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Infineon Technologies AG (IFX):企業の財務・戦略的SWOT分析
    Infineon Technologies AG (IFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Babcock & Wilcox Enterprises Inc (BW):電力:M&Aディール及び事業提携情報
    Summary Babcock & Wilcox Enterprises, Inc. (Babcock & Wilcox) is a provider of technology-based advanced fossil and renewable power generation and environmental equipment. The company offers a range of biomass-fired boilers products such as supercritical boiler, waste-to-energy boilers, heat recover …
  • U.S. Stem Cell Inc (USRM):製薬・医療:M&Aディール及び事業提携情報
    Summary U.S. Stem Cell Inc (U.S. Stem Cell), formerly Bioheart, Inc, is a biotechnology company that focuses on the discovery, development and commercialization of cell based therapeutics products. The company repairs and replaces damaged or aged tissue, cells and organs and restoring their normal f …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆